Rajeev, SP, Roberts, CA, Brown, E, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Boyland, EJ, Kemp, GJ, Perry, J, Howarth, E, Jackson, R, Wiemken, A, Schwab, R, Cuthbertson, DJ and Wilding, JPH (2023) No evidence of compensatory changes in energy balance, despite reductions in body weight and liver fat, during dapagliflozin treatment in type 2 diabetes mellitus: A randomised, double-blind, placebo-controlled, cross-over trial (ENERGIZE). Diabetes, Obesity and Metabolism. ISSN 1462-8902

Brown, E, Wilton, MM, Sprung, VS, Harrold, JA, Halford, JCG, Stancak, A, Burgess, M, Howarth, E, Umpleby, AM, Kemp, GJ, Wilding, JPH and Cuthbertson, DJ (2021) A randomised, controlled, double blind study to assess mechanistic effects of combination therapy of dapagliflozin with exenatide QW versus dapagliflozin alone in obese patients with type 2 diabetes mellitus (RESILIENT): study protocol. BMJ Open, 11 (7). ISSN 2044-6055

Howarth, E (2021) ATTENTION BIAS: A NEW TOOL FOR WELFARE ASSESSMENT IN CAPTIVE RHESUS MACAQUES. Doctoral thesis, Liverpool John Moores University.